Bamco Inc. NY decreased its stake in shares of Endava plc (NYSE:DAVA - Free Report) by 20.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 674,261 shares of the company's stock after selling 177,335 shares during the period. Bamco Inc. NY owned 1.14% of Endava worth $20,835,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of DAVA. Oppenheimer Asset Management Inc. acquired a new stake in shares of Endava during the 4th quarter worth about $215,000. Natixis Advisors LLC lifted its stake in shares of Endava by 44.8% during the fourth quarter. Natixis Advisors LLC now owns 45,340 shares of the company's stock valued at $1,401,000 after buying an additional 14,023 shares during the period. Robeco Institutional Asset Management B.V. boosted its position in Endava by 13.9% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 204,300 shares of the company's stock worth $6,313,000 after acquiring an additional 25,000 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Endava by 35.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 27,289 shares of the company's stock worth $843,000 after acquiring an additional 7,124 shares during the period. Finally, Sei Investments Co. raised its holdings in Endava by 26.1% in the 4th quarter. Sei Investments Co. now owns 118,095 shares of the company's stock valued at $3,649,000 after acquiring an additional 24,426 shares during the last quarter. Hedge funds and other institutional investors own 62.23% of the company's stock.
Endava Stock Down 0.6 %
Shares of NYSE DAVA traded down $0.12 during midday trading on Friday, reaching $19.82. 627,176 shares of the company's stock were exchanged, compared to its average volume of 482,567. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 1.90. Endava plc has a 52-week low of $16.60 and a 52-week high of $34.94. The business's fifty day moving average price is $19.48 and its two-hundred day moving average price is $25.97. The stock has a market capitalization of $1.17 billion, a PE ratio of 180.18, a price-to-earnings-growth ratio of 2.26 and a beta of 1.25.
Endava (NYSE:DAVA - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.32 by ($0.18). Endava had a net margin of 0.74% and a return on equity of 0.89%. The business had revenue of $250.63 million during the quarter, compared to analyst estimates of $197.33 million. Analysts forecast that Endava plc will post 0.57 EPS for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on DAVA shares. Susquehanna lowered their price objective on Endava from $55.00 to $50.00 and set a "positive" rating for the company in a research report on Friday, February 21st. Morgan Stanley lifted their price target on Endava from $33.00 to $35.00 and gave the company an "equal weight" rating in a report on Friday, January 31st. Finally, Needham & Company LLC cut their price objective on shares of Endava from $43.00 to $38.00 and set a "buy" rating on the stock in a report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $38.51.
Read Our Latest Research Report on DAVA
Endava Profile
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Featured Stories

Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.